Jiangsu Nhwa Pharmaceutical Hits Day Low Amid Price Pressure at CNY 27.20

Jiangsu Nhwa Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 5.23% as of September 30, 2025. The stock reached an intraday low of CNY 27.20, reflecting a challenging trading session for the company.
In terms of performance metrics, Jiangsu Nhwa's one-day performance contrasts sharply with the China Shanghai Composite, which gained 0.9%. Over the past week, the stock has seen a slight decrease of 0.91%, while it has performed positively over the past month with a gain of 9.5%. However, the one-year performance shows a decline of 14.16%, despite a 9.6% increase in profits during the same period.

The company maintains a market capitalization of CNY 24,042 million and a price-to-earnings ratio of 20.00. With a return on equity of 15.83% and a price-to-book ratio of 3.13, Jiangsu Nhwa continues to demonstrate solid financial metrics, although the current trading environment presents challenges. The stock's dividend yield stands at 1.32%, providing some return to shareholders amidst the recent volatility.